280 related articles for article (PubMed ID: 21320835)
21. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM).
Kyle RA; Dispenzieri A; Kumar S; Larson D; Therneau T; Rajkumar SV
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):74-6. PubMed ID: 21454195
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal IgM Gammopathy and Waldenström's Macroglobulinemia.
Grunenberg A; Buske C
Dtsch Arztebl Int; 2017 Nov; 114(44):745-751. PubMed ID: 29169431
[TBL] [Abstract][Full Text] [Related]
23. Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance?
Gobbi PG; Baldini L; Broglia C; Goldaniga M; Comelli M; Morel P; Morra E; Cortelazzo S; Bettini R; Merlini G
Clin Cancer Res; 2005 Mar; 11(5):1786-90. PubMed ID: 15756000
[TBL] [Abstract][Full Text] [Related]
24. A phase II trial on alpha-interferon (alpha IFN) effect in patients with monoclonal IgM gammopathy.
Rotoli B; De Renzo A; Frigeri F; Buffardi S; Marcenò R; Cavallaro AM; Ruggeri P; Liso V; Musto P; Andriani A
Leuk Lymphoma; 1994 May; 13(5-6):463-9. PubMed ID: 8069191
[TBL] [Abstract][Full Text] [Related]
25. Differential diagnosis of IgM MGUS and WM according to B-lymphoid infiltration by morphology and flow cytometry.
Ocio EM; del Carpio D; Caballero Á; Alonso J; Paiva B; Pesoa R; Villaescusa T; López-Anglada L; Vidriales B; García-Sanz R
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):93-5. PubMed ID: 21454201
[TBL] [Abstract][Full Text] [Related]
26. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
[TBL] [Abstract][Full Text] [Related]
27. Peripheral neuropathy in IgM monoclonal gammopathy and Wäldenstrom's macroglobulinemia: a frequent complication in elderly males with low MAG-reactive serum monoclonal component.
Baldini L; Nobile-Orazio E; Guffanti A; Barbieri S; Carpo M; Cro L; Cesana B; Damilano I; Maiolo AT
Am J Hematol; 1994 Jan; 45(1):25-31. PubMed ID: 7504399
[TBL] [Abstract][Full Text] [Related]
28. Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemia.
Grass S; Preuss KD; Wikowicz A; Terpos E; Ziepert M; Nikolaus D; Yang Y; Fadle N; Regitz E; Dimopoulos MA; Treon SP; Hunter ZR; Pfreundschuh M
Blood; 2011 Mar; 117(10):2918-23. PubMed ID: 21220746
[TBL] [Abstract][Full Text] [Related]
29. 6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance.
Schop RF; Van Wier SA; Xu R; Ghobrial I; Ahmann GJ; Greipp PR; Kyle RA; Dispenzieri A; Lacy MQ; Rajkumar SV; Gertz MA; Fonseca R
Cancer Genet Cytogenet; 2006 Sep; 169(2):150-3. PubMed ID: 16938573
[TBL] [Abstract][Full Text] [Related]
30. Immunoparesis in IgM gammopathies as a useful biomarker to predict disease progression.
Andrade-Campos M; Murillo-Flórez I; García-Sanz R; Giraldo P
Clin Chem Lab Med; 2017 Aug; 55(10):1598-1604. PubMed ID: 28284031
[TBL] [Abstract][Full Text] [Related]
31. Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Kyle RA; Treon SP; Alexanian R; Barlogie B; Björkholm M; Dhodapkar M; Lister TA; Merlini G; Morel P; Stone M; Branagan AR; Leblond V
Semin Oncol; 2003 Apr; 30(2):116-20. PubMed ID: 12720119
[TBL] [Abstract][Full Text] [Related]
32. Impaired class switch recombination (CSR) in Waldenstrom macroglobulinemia (WM) despite apparently normal CSR machinery.
Kriangkum J; Taylor BJ; Strachan E; Mant MJ; Reiman T; Belch AR; Pilarski LM
Blood; 2006 Apr; 107(7):2920-7. PubMed ID: 16317092
[TBL] [Abstract][Full Text] [Related]
33. Lymphoplasmacytic lymphoma with IgA paraproteinemia mimicking Waldenstrom's Macroglobulinemia.
Basu D; Pathak D; Shyambabu C; Koner BC; Swaminathan RP
Indian J Pathol Microbiol; 2004 Oct; 47(4):515-7. PubMed ID: 16295380
[TBL] [Abstract][Full Text] [Related]
34. Myelin protein P0-specific IgM producing monoclonal B cell lines were established from polyneuropathy patients with monoclonal gammopathy of undetermined significance (MGUS).
Kvarnstrom M; Sidorova E; Nilsson J; Ekerfelt C; Vrethem M; Soderberg O; Johansson M; Rosen A; Ernerudh J
Clin Exp Immunol; 2002 Feb; 127(2):255-62. PubMed ID: 11876747
[TBL] [Abstract][Full Text] [Related]
35. Paraproteinemic neuropathies.
Vital A
Brain Pathol; 2001 Oct; 11(4):399-407. PubMed ID: 11556684
[TBL] [Abstract][Full Text] [Related]
36. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
[TBL] [Abstract][Full Text] [Related]
37. Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system.
Baldini L; Goldaniga M; Guffanti A; Broglia C; Cortelazzo S; Rossi A; Morra E; Colombi M; Callea V; Pogliani E; Ilariucci F; Luminari S; Morel P; Merlini G; Gobbi P
J Clin Oncol; 2005 Jul; 23(21):4662-8. PubMed ID: 16034042
[TBL] [Abstract][Full Text] [Related]
38. Clinical features, evaluation, and treatment of patients with polyneuropathy associated with monoclonal gammopathy of undetermined significance (MGUS).
Gorson KC
J Clin Apher; 1999; 14(3):149-53. PubMed ID: 10540371
[TBL] [Abstract][Full Text] [Related]
39. Pathogenesis and morbidity of autoantibody syndromes in Waldenstrom's macroglobulinemia.
Stone MJ
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):157-9. PubMed ID: 21454221
[TBL] [Abstract][Full Text] [Related]
40. Peripheral neuropathy as clinical onset of monoclonal IgM/k-related amyloidosis.
Briani C; Ferrari S; Berno T; Visentin A; Cacciavillani M; Cavallaro T; Fedrigo M; Rizzo S; Salvalaggio A; Trentin L; Piazza F
J Peripher Nerv Syst; 2023 Jun; 28(2):262-265. PubMed ID: 36859783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]